Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nam, Bo Da | - |
dc.contributor.author | Kim, Sung Mok | - |
dc.contributor.author | Jung, Hye Na | - |
dc.contributor.author | Kim, Yiseul | - |
dc.contributor.author | Choe, Yeon Hyeon | - |
dc.date.accessioned | 2021-08-11T11:43:30Z | - |
dc.date.available | 2021-08-11T11:43:30Z | - |
dc.date.issued | 2018-11 | - |
dc.identifier.issn | 1569-5794 | - |
dc.identifier.issn | 1573-0743 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/5546 | - |
dc.description.abstract | To compare inversion time (TI) parameters, native T1, and extracellular volume (ECV) on cardiac magnetic resonance (CMR) imaging between patients with cardiac amyloidosis (CA) or hypertrophic cardiomyopathy (HCMP). Forty six patients with biopsy-confirmed CA and 30 patients with HCMP who underwent CMR were included. T1 and TI values were measured in the septum and cavity of the left ventricle on T1 mapping and TI scout images. TI values were selected at nulling point for each myocardium and blood pool. Native T1, ECV, and TI interval values were significantly different between the CA (1170.5 +/- 86.4ms, 56.7 +/- 12.2, -11.5 +/- 28.4ms) and HCMP (1059.5 +/- 63.4ms, 28.5 +/- 5.8, 66.2 +/- 25.4ms) (all p<0.001). The diagnostic performance of the TI interval (area under the ROC curve, 0.975) was not inferior to that of the ECV (0.980, p=0.776), and it was superior to that of the native T1 (0.845, p=0.004). The diagnostic performance of TI interval was comparable to that of ECV for differential diagnosis between CA and HCMP. TI interval showed the feasibility as quantitative CMR parameter when T1 mapping images are not available. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Kluwer Academic Publishers | - |
dc.title | Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1007/s10554-018-1385-2 | - |
dc.identifier.scopusid | 2-s2.0-85047828954 | - |
dc.identifier.wosid | 000447415600011 | - |
dc.identifier.bibliographicCitation | International Journal of Cardiovascular Imaging, v.34, no.11, pp 1769 - 1777 | - |
dc.citation.title | International Journal of Cardiovascular Imaging | - |
dc.citation.volume | 34 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1769 | - |
dc.citation.endPage | 1777 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | ENDOMYOCARDIAL BIOPSY | - |
dc.subject.keywordPlus | QUANTIFICATION | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | EXPANSION | - |
dc.subject.keywordPlus | VOLUME | - |
dc.subject.keywordAuthor | Amyloidosis | - |
dc.subject.keywordAuthor | Cardiovascular magnetic resonance | - |
dc.subject.keywordAuthor | Extracellular volume | - |
dc.subject.keywordAuthor | Hypertrophic cardiomyopathy | - |
dc.subject.keywordAuthor | Inversion time | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.